Genetics of osteoporosis

Oct 27, 2020 by in ENDOCRINOLOGY Comments Off on Genetics of osteoporosis

18.1 Introduction 18.1.1 Genetic diseases The concept of genetic risk for diseases has substantially evolved in the past decades from traits and diseases that run in families, to the current…

read more

Physical activity, exercise, and skeletal health

Oct 27, 2020 by in ENDOCRINOLOGY Comments Off on Physical activity, exercise, and skeletal health

22.1 Physical activity across the life span for osteoporosis and fracture prevention Physical activity (PA) is vital for musculoskeletal health and an important component of osteoporosis and fracture prevention across…

read more

Economics of osteoporosis

Oct 27, 2020 by in ENDOCRINOLOGY Comments Off on Economics of osteoporosis

29.1 Introduction Osteoporosis is a costly, major global public health problem. In the United States (US), 10 million individuals have osteoporosis and another 44 million have low bone mass (or…

read more

Cytokines and the pathogenesis of osteoporosis

Oct 27, 2020 by in ENDOCRINOLOGY Comments Off on Cytokines and the pathogenesis of osteoporosis

33.1 Receptor activator of nuclear factor-κB ligand, receptor activator of nuclear factor-κB, and osteoprotegerin Receptor activator of nuclear factor-κB (RANK) ligand (RANKL) is tumor necrosis factor (TNF) superfamily ligand 11…

read more

Race, ethnicity, and osteoporosis

Oct 27, 2020 by in ENDOCRINOLOGY Comments Off on Race, ethnicity, and osteoporosis

19.1 Introduction In this chapter, we first address some of the problems inherent in using a racial classification system for describing human variation. We then describe variations in bone and…

read more
Get Clinical Tree app for offline access